5 completed. 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow ACAM2000: new trials by email Literature Review of ACAM2000 trials Research Report on ACAM2000
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV Vaccination with ACAM2000 - Smallpox Vaccine Adverse Reaction | Phase 4 | Completed | Emergent BioSolutions | 3032 | 2015-09-01 | 2024-03-18 |
| A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000® MVA BN®, ACAM2000® - 18-42 Year Old Healthy Vaccinia-naïve Subjects | Phase 3 | Completed | Bavarian Nordic | 440 | 2015-03-01 | 2019-12-05 |
| VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV ACAM2000 - Smallpox Vaccine Adverse Reaction | Phase 3 | Completed | Emergent BioSolutions | 25 | 2010-09-13 | 2024-03-18 |
| Safety Surveillance Study of ACAM2000® Vaccinia Vaccine ACAM2000® smallpox vaccine - Smallpox | Completed | Emergent BioSolutions | 897227 | 2008-12-01 | 2024-03-18 | |
| Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults ACAM2000 Smallpox Vaccine, Vaccinia virus (calf lymph) smallpox vaccine: Dryvax® - Smallpox | Phase 2 | Completed | Emergent BioSolutions | 357 | 2003-01-01 | 2024-03-18 |
Emergent BioSolutions (4) · Bavarian Nordic (1)
United States (3) · Canada (1) · South Korea (1)
Christine Hall, PhD (1) · Phillip R Pittman, MD, MPH (1) · Ronald Brown, MD (1)